StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / oakhillbio.com

Oak Hill Bio

Oak Hill Bio (oakhillbio.com): 5 changes recorded in its website history since February 2022. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. MessagingBetween and
    BeforeOak Hill Bio is committed to developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune…
    AfterAdvancing Rare Disease Therapies Across the Finish Line

    Classifier interpretation of website text.

  2. New logosBetween and

    Added logos to its homepage: Jiaping Gu, Ph.D. and Hussein Al-Mossawi, Ph.D..

    Observed on the company’s website; business claims are not independently verified.

  3. New logosBetween and

    Added logos to its homepage: Sharon Morriss, Ph.D., Sacha Mann, Shashi Borade, Ph.D. and Kim Davis, J.D..

    Observed on the company’s website; business claims are not independently verified.

  4. New logosBetween and

    Added logos to its homepage: Ike Greenstein, M.B.A., David Colpman, Daniel Curran, M.D. and Ramy Farid, Ph.D..

    Observed on the company’s website; business claims are not independently verified.

  5. New logosBetween and

    Added logos to its homepage: Tauhid Ali, Ph.D., Josh Distler, J.D., Mark McHale, Ph.D., Victoria Niklas, M.A., M.D., Suki Malhi, Ph.D., David Rich, MPhil, Caitlin Clunie-O’Connor, D.Phil., Rachel Smith and 2 more.

    Observed on the company’s website; business claims are not independently verified.

First recorded website

Observed 3 February 2022

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Oak Hill Bio is committed to developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases.

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. July 2025 – November 2026 · 4 captures · latest observed messagingAdvancing Rare Disease Therapies Across the Finish Line

    Oak Hill Bio is a clinical-stage biotechnology company focused on acquiring and developing outstanding rare disease drugs that have been deprioritized by big pharma. The company's lead program is rugo

    This wording observed 6 November 2026.

    Inspect 4 captures in this group
    • 21 July 2025 · Advancing Rare Disease Therapies Across the Finish Line archived page
    • 19 January 2026 · Advancing Rare Disease Therapies Across the Finish Line archived page
    • 12 July 2026 · Advancing Rare Disease Therapies Across the Finish Line archived page
    • 6 November 2026 · Advancing Rare Disease Therapies Across the Finish Line current websiteHistorical capture not publicly available
  2. February 2022 – January 2025 · 6 capturesOak Hill Bio is committed to developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases.

    This wording observed 8 January 2025.

    Inspect 6 captures in this group
    • 3 February 2022 · Oak Hill Bio is committed to developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. archived page
    • 6 March 2023 · Oak Hill Bio is committed to developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. archived page
    • 26 September 2023 · Oak Hill Bio is committed to developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. archived page
    • 4 January 2024 · Oak Hill Bio is committed to developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. archived page
    • 7 July 2024 · Oak Hill Bio is committed to developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. archived page
    • 8 January 2025 · Oak Hill Bio is committed to developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. archived page

Cite this record

StartupHistory, “Oak Hill Bio” company record, https://startuphistory.org/c/oakhillbio.com

Machine-readable: /c/oakhillbio.com.json. How changes are found: method.